DrugTheGuide
Pharmacokinetics

Accumulation Factor R

The ratio of drug concentration at steady state to concentration after the first dose — quantifying how much drug builds up with repeated dosing at a fixed interval.

Definition and Formula

When a drug is administered repeatedly at a fixed dose and interval, drug accumulates between doses until a steady state is reached. The accumulation factor R describes how much higher drug concentrations at steady state are compared to after a single dose:

R = Cmax,ss / Cmax,1 = 1 / (1 − e−ke·τ)

Where ke = elimination rate constant = ln(2)/t½, and τ = dosing interval.

Equivalently expressed using half-life: R = 1 / (1 − 0.5τ/t½).

A value of R = 1 means no accumulation (the drug is fully eliminated before the next dose). R = 2 means steady-state concentrations are twice first-dose concentrations. Background on repeat dosing and accumulation: NCBI StatPearls pharmacokinetics ↗.

Accumulation Factor at Common τ/t½ Ratios

τ / t½ ratio Accumulation factor R Interpretation
4 × t½ 1.07 Almost no accumulation — drug mostly eliminated
2 × t½ 1.14 Minimal accumulation
1 × t½ 1.44 Moderate — SS is 44% higher than first dose
0.5 × t½ 2.41 Significant — SS is 2.4× first dose
0.25 × t½ 4.57 High accumulation — typical of q.i.d. drugs with long t½
0.1 × t½ 10.4 Very high — e.g. amiodarone-type kinetics

Clinical Applications

The accumulation factor is directly relevant to:

  • Loading dose calculation — the loading dose needed to rapidly achieve steady-state target concentrations ≈ R × maintenance dose × Vd / F. See our loading dose glossary.
  • Narrow therapeutic index drugs — high R values for NTI drugs (digoxin, warfarin, lithium) mean small increases in dosing frequency can cause large concentration jumps into the toxic range.
  • Modified-release formulations — extended-release products flatten peak-to-trough fluctuation; twice-daily rather than four-times-daily reduces R and concentration swings. See the FDA non-compartmental analysis guidance ↗.
  • Renal or hepatic impairment — reduced clearance prolongs t½, increases R, and raises steady-state concentrations for drugs given at standard intervals. Dose reduction or interval extension is required. See our renal dosing guide and hepatic dosing guide.

Reference: PubMed: drug accumulation and multiple dosing ↗.

FAQ

What is the accumulation factor in pharmacokinetics?
The accumulation factor (R) quantifies how much higher drug concentrations become at steady state compared to after a single dose, when the drug is given repeatedly at a fixed interval. R = 1 / (1 − e^(−ke × τ)), where ke is the elimination rate constant and τ is the dosing interval. A value of R = 2 means steady-state concentrations are twice as high as after the first dose.
When does significant drug accumulation occur?
Significant accumulation occurs when the dosing interval (τ) is short relative to the half-life. If τ equals the half-life, R ≈ 1.44 (44% higher at steady state). If τ is much shorter than the half-life, accumulation is large. Drugs with long half-lives such as amiodarone (t½ = 40–55 days) or fluoxetine (t½ = 1–3 days for parent) accumulate substantially.
How does the accumulation factor relate to loading dose?
The accumulation factor tells you how much drug is required to achieve steady-state concentrations immediately. A loading dose = R × maintenance dose (approximately) achieves steady-state target concentrations on the first dose, rather than waiting 4–5 half-lives. This is used for drugs like digoxin, amiodarone, and vancomycin.
What is the peak-to-trough ratio at steady state?
The peak-to-trough ratio at steady state is Cmax,ss / Cmin,ss = 1 / e^(−ke × τ) = e^(ke × τ). A larger ratio means greater fluctuation between doses. Narrow therapeutic index drugs with high fluctuation require careful dosing interval selection or modified-release formulations to stay within the therapeutic window.